<DOC>
	<DOCNO>NCT00452569</DOCNO>
	<brief_summary>The primary objective compare time progression ( TTP ) three daily dos thalidomide ( 100 , 200 400 mg ) high-dose dexamethasone relapse refractory multiple myeloma ( MM ) patient subsequently select optimum thalidomide dose term median TPP toxicity .</brief_summary>
	<brief_title>Efficacy Safety Study 3 Thalidomide Doses Treatment Relapsed Refractory Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Male female patient , age ≥ 18 year time signing informed consent form Patients previously diagnose MM receive 1 &amp; 3 prior line treatment disease , require therapy disease progression Secretory MM measurable level monoclonal protein serum ( &gt; 10 g/L IgG Mprotein &gt; 5 g/L IgA Mprotein ) urine ( ≥ 200 mg/ 24hours ) ; Patient follow rare subclass immunoglobulin : IgD , IgE , IgM include study level monoclonal protein serum &gt; 5g/L ≥ 200 mg/24hours urine . As IgM immunoglobulin isotype relate Waldenstrom 's macroglobulinemia , important distinguish include study patient Waldenstrom 's macroglobulinemia . ECOG performance status 0 , 1 , 2 Life expectancy &gt; 3months Able adhere study visit schedule &amp; protocol requirement Women childbearing potential must agree use 2 method contraception least 4weeks start therapy , Treatment Period , &amp; 4 week last dose Males must agree use barrier contraception ( latex condom ) engage reproductive activity Treatment Period &amp; 4 week last dose Written , informed consent Any serious medical condition , laboratory abnormality , psychiatric illness would prevent patient signing Informed Consent Form Pregnant lactate woman . A serum βhCG pregnancy test must perform Screening visit female patient childbearing potential . If test positive , patient must exclude study . Confirmation patient pregnant must establish negative serum urinary pregnancy test result obtain 1day prior Baseline visit ( day visit result available drug delivery ) . A pregnancy test require naturally postmenopausal woman ( menses time precede 24 consecutive month ) surgically sterilize woman ( hysterectomy , bilateral ovariectomy , bilateral salpingectomy ) Nonsecretory MM Any follow laboratory abnormality : Absolute neutrophil count ( ANC ) &lt; 500 cells/mm3 ( 0.5 x 109/L ) ; Platelet count &lt; 30,000/mm3 ( 30.0 x 109L ) without transfusion support within 7 day test ; Serum creatinine &gt; 3.0mg/dL ( 265μmol/L ) ; Serum aspartate aminotransferase ( ASAT ) alanine aminotransferase ( ALAT ) &gt; 3.0 x upper limit normal ( ULN ) ; Serum total bilirubin &gt; 2.0mg/dL ( 34μmol/L ) Any condition , include presence laboratory abnormality , place patient unacceptable risk s/he participate study , confound ability interpret data study Severe cardiac dysfunction ( accord New York Heart Association [ NYHA ] classification IIIIV ) Severe bradycardia ( &lt; 50bpm ) Peripheral neuropathy ≥Grade 2 severity ( accord NCI CTC Version 3.0 ) Prior history malignancy ( except basal cell squamous cell carcinoma skin carcinoma situ cervix breast ) unless patient free disease ≥5years Patient receive chemotherapy , corticosteroid ( &gt; 10 mg/day prednisone equivalent continuous dose ) within 4 week randomization Previously treat thalidomide thalidomide derivative Patients refractory highdose dexamethasone ( define experience less PR dexamethasone , PD within 6months discontinue dexamethasone , discontinue dexamethasone ≥Grade 3 dexamethasonerelated toxicity . Previous highdose dexamethasone therapy define &gt; 500mg dexamethasone equivalent 10week period , whether administer alone part VAD regimen ) Contraindications highdose dexamethasone Active chronic gastrointestinal ulcer , active viral infection ( herpes , varicella , HIV , hepatitis B , hepatitis C ) , glaucoma , uncontrolled hypertension , diabetes mellitus , unless well control &amp; strict supervision dexamethasone treatment Patient enrol another clinical trial participate another trial last 4weeks randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Relapsed Refractory Multiple Myeloma</keyword>
</DOC>